Cadence Bank NA’s Novartis NVS Stock Holding History

Cadence Bank NA’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,633	Closed	-$476K	–	148
2022 Q2	$476K	Sell	5,633 -3,118	-36%	-$274K	0.15%	127
2022 Q1	$767K	Hold	8,751	–	–	0.21%	107
2021 Q4	$766K	Sell	8,751 -5,982	-41%	-$497K	0.21%	106
2021 Q3	$1.21M	Sell	14,733 -2,353	-14%	-$212K	0.36%	72
2021 Q2	$1.56M	Sell	17,086 -891	-5%	-$79.3K	0.47%	58
2021 Q1	$1.54M	Sell	17,977 -2,908	-14%	-$261K	0.48%	58
2020 Q4	$1.97M	Sell	20,885 -134	-0.6%	-$11.7K	0.7%	42
2020 Q3	$1.83M	Buy	21,019 +1,241	+6%	+$108K	0.71%	39
2020 Q2	$1.73M	Buy	19,778 +803	+4%	+$69.3K	0.73%	40
2020 Q1	$1.56M	Sell	18,975 -5,454	-22%	-$487K	0.8%	33
2019 Q4	$2.31M	Buy	24,429 +915	+4%	+$82.1K	0.85%	33
2019 Q3	$2.04M	Buy	23,514 +1,056	+5%	+$94.8K	0.8%	37
2019 Q2	$2.05M	Sell	22,458 -3,428	-13%	-$290K	0.8%	36
2019 Q1	$2.23M	Buy	25,886 +1,078	+4%	+$86.5K	0.87%	32
2018 Q4	$1.91M	Buy	24,808 +673	+3%	+$52.4K	0.86%	32
2018 Q3	$1.86M	Buy	24,135 +70	+0.3%	+$5.17K	0.71%	39
2018 Q2	$1.63M	Sell	24,065 -2,572	-10%	-$177K	0.67%	46
2018 Q1	$1.93M	Sell	26,637 -318	-1%	-$24.2K	0.77%	42
2017 Q4	$2.03M	Sell	26,955 -458	-2%	-$34.6K	0.74%	43
2017 Q3	$2.11M	Sell	27,413 -119	-0.4%	-$8.99K	0.8%	37
2017 Q2	$2.06M	Sell	27,532 -196	-0.7%	-$13.9K	0.94%	30
2017 Q1	$1.84M	Buy	27,728 +1,569	+6%	+$105K	0.85%	38
2016 Q4	$1.71M	Sell	26,159 -13,453	-34%	-$873K	0.8%	38
2016 Q3	$2.8M	Buy	39,612 +15,702	+66%	+$1.14M	1.27%	24
2016 Q2	$1.77M	Buy	23,910 +6,315	+36%	+$436K	0.87%	29
2016 Q1	$1.14M	Buy	17,595 +1,143	+7%	+$77.8K	0.59%	49
2015 Q4	$1.27M	Buy	16,452 +1,558	+10%	+$124K	0.68%	36
2015 Q3	$1.23M	Buy	14,894 +8,399	+129%	+$747K	0.71%	35
2015 Q2	$573K	Buy	6,495 +454	+8%	+$41.6K	0.37%	50
2015 Q1	$533K	Buy	6,041 +1,430	+31%	+$127K	0.3%	75
2014 Q4	$383K	Buy	4,611 +52	+1%	+$4.31K	0.2%	97
2014 Q3	$385K	Buy	4,559 +442	+11%	+$35.8K	0.21%	93
2014 Q2	$334K	Buy	4,117 +673	+20%	+$52.9K	0.18%	108
2014 Q1	$262K	Buy	3,444 +412	+14%	+$30K	0.16%	109
2013 Q4	$218K	Buy	3,032 +118	+4%	+$8.2K	0.12%	145
2013 Q3	$201K	Buy	+2,914	New	+$193K	0.12%	134

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cadence Bank NA's NVS Position: Q3 2022 in Review

Cadence Bank NA sold out of Novartis (NVS) in Q3 2022, closing a stake of 5,633 shares — an estimated $476K sold.

Cadence Bank NA first reported a position in NVS in Q3 2013 and held it in 36 quarters. The position peaked at $2.8M in Q3 2016. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.

Cadence Bank NA reported no remaining Novartis position as of Q3 2022 after selling out during the quarter.
Cadence Bank NA sold 5,633 Novartis shares in Q3 2022, an estimated $476K.
Cadence Bank NA first reported a position in Novartis in Q3 2013 and held it in 36 quarters.
Cadence Bank NA's Novartis position peaked at $2.8M in Q3 2016.
1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.

Based on Cadence Bank NA's 13F filing for Q3 2022, filed 27 Oct 2022.